La Jolla, CA, United States of America

Nicholas Cosford

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Nicholas Cosford

Introduction

Nicholas Cosford is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of biological studies, particularly in the development of therapeutic methods. With a total of 3 patents, his work focuses on innovative treatments for various diseases.

Latest Patents

Among his latest patents, Cosford has developed ULK1 inhibitors and methods using the same. This invention provides a method for treating a disease or condition in a subject. The method involves co-administering a therapeutically effective amount of at least one ULK1-inhibiting pyrimidine alongside an mTOR inhibitor. This dual approach aims to enhance treatment efficacy for patients in need.

Career Highlights

Cosford has had a distinguished career, working at notable institutions such as the Salk Institute for Biological Studies and the Sanford Burnham Prebys Medical Discovery Institute. His research has been pivotal in advancing our understanding of biological processes and therapeutic interventions.

Collaborations

Throughout his career, Cosford has collaborated with esteemed colleagues, including Reuben J. Shaw and Daniel F. Egan. These partnerships have fostered a collaborative environment that encourages innovation and discovery.

Conclusion

Nicholas Cosford's contributions to the field of biological studies through his patents and collaborations highlight his role as a leading inventor. His work continues to influence the development of new therapeutic methods, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…